l A B S T R A C T The plasma disappearance rate (metabolic clearance rate) of administered intact parathyroid hormone (intact PTH) was analyzed in awake dogs with indwelling hepatic and renal vein catheters. The metabolic clearance rate (MCR) of intact PTH was found to be very rapid, 21.6±3.1 ml/min per kg in 11 normal dogs. The liver accounted for the greatest fraction of the MCR of intact PTH (61±4%) by virtue of an arterial minus venous (a -v) difference across the liver of 45±3%. The renal uptake of intact PTH accounted for 31±3% of the MCR of intact PTH. The renal a -v difference for intact PTH of 29±2% was significantly greater than the filtration fraction indicating renal uptake of intact PTH at sites independent of glomerular filtration. Together, the hepatic and renal clearances of intact PTH accounted for all but a small fraction of the MCR of intact PTH. The MCR of intact PTH, rendered biologically inactive by oxidation, was markedly decreased to 8.8±1 ml/min per kg. The a -v difference of oxidized intact PTH was reduced both in the liver and kidney. These data suggested that the high uptake rates of intact PTH are dependent, at least in part, upon sites recognizing only biologically active PTH.
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Chronic renal failure (CRF) decreased the MCR of intact PTH to 11.3±1.3 ml/min per kg (n = 10). Both the hepatic and renal a -v differences of intact PTH were reduced in dogs with CRF. This resulted in reductions in the hepatic and renal clearances ofintact PTH. These studies identify the liver as a major extrarenal site of PTH metabolism affected by CRF. They suggest that INTRODUCTION In recent years, our knowledge of the peripheral metabolism of parathyroid hormone (PTH)l has been greatly enhanced. Circulating PTH has been shown to be a heterogenous mixture of intact hormone (PTH 1-84) and hormone fragments (1) (2) (3) (4) (5) (6) (7) . In addition, work by several authors (3, (8) (9) (10) (11) has demonstrated different specificities among the target organs for the form of PTH that each organ removes from the circulation. For instance, several authors have demonstrated that intact PTH is removed from the circulation by the liver (3, 4, 8, 9) . A previous report from our laboratory suggested that hepatic uptake of PTH is specific for intact PTH 1-84, whereas no hepatic uptake of carboxy terminal PTH fragments or synthetic b-PTH was demonstrable (9) . In contrast, specific uptake mechanisms for the synthetic amino terminal fragment of PTH (syn b-PTH were demonstrated in the isolated perfused canine bone in vitro but only minor uptake rates ofintact hormone were demonstrable (11) . The kidney appears to have specific uptake mechanisms for both the intact hormone and amino tenninal fragment of PTH at sites independent of glomerular filtration (10) . Yet, the kidney also nonspecifically removes all forms of immunoreactive PTH (i-PTH) through the mechanism ofglomerular filtration and tubular reabsorption (10, 12) . This latter process appears to be a nonspecific small peptide cleavage mechanism important in protein catabolism (13, 14) .
In the face of these advances, our quantitative knowledge of the metabolism of intact PTH remains inadequate. The metabolism of the hormone is thought to be rapid, judging from the rapid initial rates of disappearance of PTH following its addition to the circulation (1, 3, 15, 16 (3, 17) . The liver has been identified as having the greatest uptake rate for intact hormone (3, 9, 17) . Studies by D'Amour et al. (17) suggest that most of hepatic PTH uptake is localized to Kupffer cells, and that hepatic cleavage of intact PTH and production of C-terminal fragments can be attributed to this cell type. However, data from our laboratory (18) and others (19, 20) (5) . Our initial attempts to identify this site failed because of the limitation of the C-terminal immunoassay being used. We undertook the present studies for several purposes: first, to provide further quantitation of the MCR of intact PTH; second, to examine the uptake of intact PTH by the liver and the kidney comparing the uptake of biologically active and oxidized hormone; third, to determine individual organ contributions to the total MCR of intact PTH; and finally, to examine the effects of CRF on the metabolism of intact hormone in order to identify the site of impaired extrarenal PTH metabolism in CRF.
METHODS
Preparation of dogs. Mongrel dogs weighing 14-28 kg were fed a standard high protein Purina dog chow (RalstonPurina Co., St. Louis, Mo.) and had free access to water. In those dogs in whom the hepatic metabolism of PTH was studied, catheters were placed in the portal vein and the left common hepatic vein as described previously (9) . The method of hepatic vein catheterization was originally described by Shoemaker et al. (21) . Catheter patency was maintained by intermittent filling with heparin. After surgery, the dogs were followed closely for resumption of normal dietary and bowel habits. The shortest time interval after surgery to study was 72 h. Dogs that were not eating full rations or having normal formed stools were not studied. In those dogs in whom the metabolism of PTH by the kidney was studied, polyethylene catheters were advanced from the inferior vena cava into the renal vein at laparotomy. The catheters were filled with heparin, and the studies were performed 24-48 h following surgery.
CRF was induced by 75-85% infarction of the left kidney followed by contralateral nephrectomy as previously described (5) . After induction of renal failure, the dogs were stabilized for at least 4 wk before placement of hepatic, portal, or renal vein catheters and performance of PTH metabolism studies.
Study protocol. Dogs were studied awake and resting in a sling after a 12-h fast. The femoral artery was catheterized by the Seldinger technique (22) and a polyethylene catheter was advanced into the aorta to the approximate level of the celiac axis or the renal artery. A hind leg vein catheter was placed for infusions of solutions and injections of PTH. During studies of hepatic PTH metabolism, hepatic plasma flow was measured by the previously reported methods (9, 23) , using constant infusions of Indocyanine Green (ICG; Hynson, Westcott, Dunning, Inc., Baltimore, Md.). The hepatic arterial venous difference (a -v) for ICG also served as a marker for adequacy of hepatic venous sampling to exclude contamination of samples with inferior vena cava blood (23) . In studies of the renal metabolism of intact PTH, glomerular filtration rate was measured by exogenous creatinine clearance and renal plasma flow was measured by the extraction and clearance of paraminohippurate (PAH). PAH extraction also served as a marker of adequacy of renal vein sampling. In both types of studies, base-line periods were conducted for determination of catheter function and renal and hepatic plasma flow determinations. Then constant infusions of bovine PTH (b-PTH 1-84) were begun following bolus injections at 5-10 ,ug at a rate of 0.2-0.7 ,ug/min. This infusion rate was found to maintain immunoreactive intact PTH in the plasma at a concentration of 0.5-5.2 ng/ml. These levels are lower than those at which we have reported circulating amino terminal fragments following injections of intact b-PTH 1-84 in dogs (5, 9) . Equilibration of PTH levels for 50 min was allowed before experimental periods were begun. Then 5-10 experimental samples were obtained from the aorta and/or the renal, hepatic, and portal veins simultaneously. PTH infusions were administered through the hind leg vein catheter. The PTH was added to dog plasma obtained from each animal before the infusion and was kept under ice during the infusion. The use of the dog plasma as a carrier for the PTH was designed to limit loss of PTH through adsorption to the infusion apparatus (24) . Concentration of PTH in the infusate was measured at the beginning, middle, and end of the infusion and remained stable throughout the duration of the infusions.
Source ofPTH. The b-PTH 1-84 used in these studies was obtained from three lots of hormone prepared from extracts of bovine parathyroid glands. PTH was purified according to the method of Hamilton et al. (25) , except that final purification by carboxy methyl cellulose ion exchange chromatography was performed using a linear gradient of ammonium acetate in 8 M urea as the elution buffer. Hormone preparations so isolated revealed single peaks of radioimmunoassayable PTH-like activity when subjected to polyacrylamide gel electrophoresis (Fig. IA) . The biological activity of the preparations was 2,000 U/mg in a renal cortical adenylate cyclase assay (26) . The standard, against which the biological activity of our preparations was compared, was prepared and standardized by Hamilton et al. (25) . Synthetic bovine PTH 1-34 (syn b-PTH 1-34) was obtained from Beckman Instruments, Inc., Spinco Div., Palo Alto, Calif.). cortical adenylate cyclase assay (26) . It also failed to induce phosphaturia in the dogs studied in the present studies. Radioimmunoassay methods. iPTH levels in plasma, infusates, and polyacrylamide gel eluates were determined by radioimmunoassay methods described in detail previously (5, 9) . The CH9N antiserum specific for the amino terminal portion of b-PTH 1-84 was used in the determinations of immunoassayable intact PTH. The amino terminal specificity of this antiserum stems from the fact that it was produced by a cockerel immunized with syn b-PTH 1-34. The antiserum was used in a dilution of 1:25,000 in these studies. i-PTH levels below those where amino terminal fragments would be detectable in the plasma samples. To confirm that amino terminal fragments were not contributing significantly to i-PTH levels in these studies, plasma samples from each study were subjected to polyacrylamide gel electrophoresis. Eluates from the gels were subjected to radioimmunoassay for detection of amino terminal fragments. In addition, samples from the polyacrylamide gel eluates were also subjected to C-terminal radioimmunoassay for comparison of the immunoreactive forms of C-terminal PTH in the gel eluates. In these assays, the CH9 antiserum, a Cterminal antiserum previously described (5, 9), was used as the binding ligand and '25I-b-PTH 1-84 as the radioiodinated tracer and b-PTH 1-84 as the standard. Gel electrophoresis was perform-ed in a tube gel apparatus using 10% (wt/vol) acrylamide and 1% (wt/vol) bis-acrylamide gels in 8 M urea according to the method of Riesfield et al. (27) , as previously described (26) . 2-mm slices of the gels were agitated for 24 h in 0.1 M sodium barbital buffer, pH 8.6 containing 10% plasma and 500 U/ml of Trasylol (FBA Pharmaceuticals, New York), before immunoassay of PTH. The extraction efficiency from the gels was 75-85% for both b-PTH 1-84 and syn b-PTH 1-34. As shown in Fig. 1 , polyacrylamide gel electrophoresis of plasma samples revealed i-PTH eluting from the gels only in the area of the b-PTH 1-84 standard. The C-terminal immunoassays of the same samples (data not shown) revealed multiple fragment peaks besides the intact hormone peak. These results indicate that the radioimmunoassay system using the CH9N antiserum, b-PTH 1-84 standard, and l2I1-b-PTH 1-84 tracer indeed represented an immunoassay of intact PTH at the levels of PTH obtained in the present studies.
Concentration of plasma samples. Plasma intact PTH levels obtained in several studies were too low for direct application to polyacrylamide gels since sample volume in the gels system was limited (maximum, 100 ,lI). To check for immunoassayable amino terminal fragments in these plasma samples, they were concentrated prior to undergoing polyacrylamide gel electrophoresis. Concentration of PTH was performed by the technique of adsorption of PTH to microfine silica (Quso G-32) and elution from the silica Hepatic and Renal Handling of Intact Parathyroid Hormone by acetone/acetic acid. Quso, 2.5 mg/ml plasma, was added to each sample to be concentrated. Plasma was then centrifuged at 2,500 rpm at 5C for 10 min and the supernate was discarded. The precipitate was washed with 2 ml of distilled water and recentrifuged. Then, 0.5 ml of 30% acetone, 0.2% acetic acid, and 1.5 ml of H20 were added to the precipitate. After mixing, the samples were recentrifuged and the supernates were lyophilized and reconstituted in 200 ,ul of 0.1 M acetic acid in 8 M urea for gel electrophoresis. Known amounts of b-PTH 1-84 and syn b-PTH 1-34 were added to hypoparathyroid plasma and also subjected to the adsorption technique for determination of recoveries. 60-80% of both peptides were recovered in the lyophilized eluates from the Quso. The plasma samples designated by * and A in Fig. 1 In dogs with CRF, the MCR of intact PTH was reduced to 10.7±+1.4 ml/min per kg, not significantly different from the CRF group shown in Table I . The a -v difference for intact PTH across the chronically diseased kidney was 20±1%, a value very similar to the filtration fraction and significantly reduced from the a -v difference of intact PTH across the normal dog kidney (P < 0.005). Thus, the renal clearance of intact PTH in CRF is decreased not only by the decreased renal plasma flow but also by the decrease in the percent a -v difference. This differs from the previously reported results for C-terminal i-PTH (5) , where the reduction of renal clearance resulted solely from a reduction in plasma flow while the a -v difference for C-terminal i-PTH remained constant. The severe reduction in renal clearance of intact PTH resulted in a reduction in the renal contribution to the total MCR to 9±1%.
The rapid MCR of intact PTH and the high levels of hepatic and renal intact PTH uptake shown above may, in part, be due to uptake mechanisms recognizing only biologically active PTH. To analyze this possibility, we studied the metabolism of oxidized, biologically inactive intact PTH. PTH, obtained from the same lots used in the studies reported above, was oxidized and infused into five normal dogs with indwelling hepatic (3) or renal (2) vein catheters. These dogs had been used previously in the studies reported in Tables I and II . Infusion of intact PTH had resulted in a reduction of tubular reabsorption of phosphate from a fasting level of 96 to 77%. The infusion of oxidized PTH in the animals resulted in no reduction of the tubular reabsorption of phosphate (Table III) . Tables I and  II for other abbreviations. vein catheters, the renal PAH extraction was 73% and the filtration fraction was 21%. The renal a -v difference for oxidized b-PTH 1-84 was 21%. The reduction in the renal a -v difference of oxidized PTH observed when compared to b-PTH 1-84 resulted in a reduction of renal PTH clearance from 7.2 ml/min per kg to 4.9 ml/min per kg, a value that accounted for 55% of the total MCR. The apparent increase in the renal contribution to total MCR in the studies with oxidized PTH is similar to the renal contribution to total MCR previously demonstrated by us for C-terminal i-PTH. These data suggest that the body's handling of biologically inactive intact PTH is significantly altered when compared to the handling of biologically active intact hormone. The reduction in the renal a -v difference of oxidized PTH was compatible with the major portion of PTH uptake now being accounted for by glomerular filtration and tubular reabsorption as others using oxidized iodinated PTH have suggested (12) . One possible explanation, for the reduced MCR of oxidized b-PTH 1-84, would be association of the oxidized hormone with large plasma proteins that should then decrease the uptake of oxidized PTH from plasma. Nonspecific association of radiolabeled oxidized intact PTH to plasma proteins in column elution buffers is well known (33, 34) . The plasma samples taken at various times following single injections of both b-PTH 1-84 and oxidized b-PTH 1-84 into dogs, were subjected to gel permeation chromatography using Bio-gel P-100 (Bio-Rad Laboratories, Richmond, Calif.). The (3, 17) . In fact, Neuman et al. (3) , using radiolabeled intact PTH by a technique reported to preserve biological activity, demonstrated increasing hepatic PTH uptake associated with increasing biological activity of the hormone. The renal a -v difference for intact PTH reported here of 29% was significantly higher than the uptake rate, which could be accounted for by glomerular filtration alone. This nonglomerular uptake of PTH may possibly represent binding to PTH-specific receptors. If this were the case, one might expect a decrease in the renal uptake of intact PTH following inactivation of the hormone. In fact, previous investigators (37) have demonstrated lack of PTH binding to renal receptors following oxidation of the hormone. Our results demonstrated a reduction in the renal a -v difference for intact PTH from 29 to 20% following oxidization of the hormone. This value is not different from the filtration fraction and thus largely explainable by glomerular filtration. Thus, it appears that a specific renal uptake mechanism recognizing only biologically active PTH was demonstrable in our current studies.
The effects of CRF on the metabolism of intact PTH were dramatic. There was a marked reduction in the MCR of intact PTH. This was contributed to by a reduction of 38% in the hepatic a -v difference for intact PTH that resulted in a marked decrease in hepatic clearance of the hormone. This identifies the liver as an extrarenal site of PTH metabolism affected by CRF. It probably identifies the liver as the extrarenal sites of PTH metabolism affected by CRF in our previous studies (5) . CRF also decreased the renal clearance of intact PTH. In contrast to our previous report (5) , the reduction in renal clearance was due to both a reduction in the a -v difference for intact PTH and the reduction in renal plasma flow. Further studies are required to investigate the effect of CRF on the characteristics of PTH receptor binding.
In summary, the studies reported here demonstrate very rapid MCR of intact PTH contributed to chiefly by the liver and the kidney. The rapid total MCR, and the high rate of hepatic and renal uptake appear to be partially dependent on PTH uptake at sites recognizing only biologically active intact PTH. CRF markedly reduced the total MCR of intact PTH by decreasing both extrarenal (hepatic) and renal PTH uptake. Thus, CRF appears to negatively affect uptake rates by the major organs responsible for the metabolism of intact PTH.
